Direct Type I Interferon Signaling in Conventional Dendritic Cells and T Help are Required for Cross-Priming AAV Capsid-Specific CD8+ T Cells

被引：0
|
作者：
Shirley, Jamie L. [1 ]
Herzog, Roland W. [2 ]
机构：
[1] Univ Florida, Pediat, Gainesville, FL USA
[2] Indiana Univ, Pediat, Indianapolis, IN 46204 USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
145
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide
    Henry, Jake Y.
    Labarthe, Marie-Christine
    Meyer, Brendan
    Dasgupta, Prokar
    Dalgleish, Angus G.
    Galustian, Christine
    [J]. IMMUNOLOGY, 2013, 139 (03) : 377 - 385
  • [22] Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells
    Kammerer, R
    Stober, D
    Riedl, P
    Oehninger, C
    Schirmbeck, R
    Reimann, J
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (01): : 108 - 117
  • [23] Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon
    Chen, WS
    Masterman, KA
    Basta, S
    Haeryfar, SMM
    Dimopoulos, N
    Knowles, B
    Bennink, JR
    Yewdell, JW
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (01) : 194 - 199
  • [24] Peptidases released by necrotic cells control CD8+ T cell cross-priming
    Gamrekelashvili, Jaba
    Kapanadze, Tamar
    Han, Miaojun
    Wissing, Josef
    Ma, Chi
    Jaensch, Lothar
    Manns, Michael P.
    Armstrong, Todd
    Jaffee, Elizabeth
    White, Ayla O.
    Citrin, Deborah E.
    Korangy, Firouzeh
    Greten, Tim F.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11): : 4755 - 4768
  • [25] LT-βετα-R Signaling in dendritic cells induces a type 1 IFN response that integrates with CD40-derived signals for cross-priming of CD8+ T cells
    deLuca, Leslie Summers
    Ng, Dennis
    Gao, Yunfei
    Lin, Albert
    Dissanayake, Dilan
    Rahbar, Ramtin
    Ohashi, Pamela S.
    Gommerman, Jennifer L.
    [J]. CYTOKINE, 2010, 52 (1-2) : 19 - 20
  • [26] RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
    Yatim, Nader
    Jusforgues-Saklani, Helene
    Orozco, Susana
    Schulz, Oliver
    da Silva, Rosa Barreira
    Reis e Sousa, Caetano
    Green, Douglas R.
    Oberst, Andrew
    Albert, Matthew L.
    [J]. SCIENCE, 2015, 350 (6258) : 328 - +
  • [27] An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T Cells
    Palaschak, Brett
    Marsic, Damien
    Herzog, Roland W.
    Zolotukhin, Sergei
    Markusic, David M.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 5 : 142 - 152
  • [28] The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8+ T cell generation
    Gottschalk, Catherine
    Mettke, Elisabeth
    Kurts, Christian
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [29] Impact of CD8+ DC depletion on in vivo cross-priming of CD8 T-cells
    Lin, M
    Zhan, Y
    Lew, AM
    [J]. TISSUE ANTIGENS, 2005, 66 (05): : 479 - 480
  • [30] AAV-2 capsid-specific CD8+T cells limit the duration of gene therapy in humans and cross-react with AAV-8 capsid.
    Mingozzi, Federico
    Maus, Marcela V.
    Sabatino, Denise E.
    Hui, Daniel J.
    Rasko, John E. J.
    Ragni, Margaret V.
    Manno, Catherine Scott
    Ertl, Hildegund C. J.
    High, Katherine A.
    [J]. BLOOD, 2006, 108 (11) : 138A - 139A
12345